- Home
- RFL vs RPTX Comparison
RFL vs RPTX Comparison
Compare RFL & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- RPTX
- Stock Information
- Founded
- RFL 2017
- RPTX 2016
- Country
- RFL United States
- RPTX Canada
- Employees
- RFL N/A
- RPTX N/A
- Industry
- RFL Real Estate
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- RFL Finance
- RPTX Health Care
- Exchange
- RFL Nasdaq
- RPTX Nasdaq
- Market Cap
- RFL 54.4M
- RPTX 64.8M
- IPO Year
- RFL N/A
- RPTX 2020
- Fundamental
- Price
- RFL $1.44
- RPTX $1.54
- Analyst Decision
- RFL
- RPTX Strong Buy
- Analyst Count
- RFL 0
- RPTX 3
- Target Price
- RFL N/A
- RPTX $4.50
- AVG Volume (30 Days)
- RFL 58.4K
- RPTX 90.2K
- Earning Date
- RFL 06-11-2025
- RPTX 08-08-2025
- Dividend Yield
- RFL N/A
- RPTX N/A
- EPS Growth
- RFL N/A
- RPTX N/A
- EPS
- RFL N/A
- RPTX N/A
- Revenue
- RFL $732,000.00
- RPTX $250,000.00
- Revenue This Year
- RFL N/A
- RPTX N/A
- Revenue Next Year
- RFL N/A
- RPTX N/A
- P/E Ratio
- RFL N/A
- RPTX N/A
- Revenue Growth
- RFL 35.56
- RPTX N/A
- 52 Week Low
- RFL $1.28
- RPTX $0.89
- 52 Week High
- RFL $3.19
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- RFL 31.57
- RPTX 51.38
- Support Level
- RFL $1.66
- RPTX $1.54
- Resistance Level
- RFL $1.67
- RPTX $1.60
- Average True Range (ATR)
- RFL 0.09
- RPTX 0.04
- MACD
- RFL -0.03
- RPTX -0.00
- Stochastic Oscillator
- RFL 0.00
- RPTX 45.83
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.